Board approves related party deals with S Labs Hygiene Care: Rs.1 crore CCPS investment, sale transactions up to Rs.25 crore; EGM on…

Proposed investment up to Rs.1,00,00,000 in Compulsory Convertible Preference Shares (CCPS).

Mon 28 Sep 2026

CCPS Investment

Proposed investment up to Rs.1,00,00,000 in Compulsory Convertible Preference Shares

Sale Transactions Limit

Proposed sale transactions up to an aggregate value of Rs.25,00,00,000

Working Capital Loan

Unsecured working capital loan up to Rs.1,00,00,000 from Non-Executive Director Mr. Ravikanth Naga Pattabhi Chopperla

Target Incorporation Date

S Labs Hygiene Care Private Limited incorporated on 10.07.2026

EGM Date and Time

EGM scheduled for Monday, 26.10.2026 at 11.00 a.m. via video conference

What the board approved

At its meeting on 28.09.2026 (5:00 p.m. to 5:30 p.m.), the board of Samsrita Labs approved, subject to prior shareholder approval valid for not more than one year:

• A material related party transaction with S Labs Hygiene Care Private Limited for a proposed investment up to Rs.1,00,00,000 in Compulsory Convertible Preference Shares (CCPS).
• A material related party transaction for proposed sale transactions with the same entity up to an aggregate value of Rs.25,00,00,000.
• Availing an unsecured loan up to Rs.1,00,00,000 for working capital from Mr. Ravikanth Naga Pattabhi Chopperla, Non-Executive Director.

About the counterparty

• S Labs Hygiene Care Private Limited was incorporated on 10/07/2026; financial information for FY 2025-26 and earlier years is not applicable.
• Issued and paid-up capital: 99,999 equity shares of Rs.10 each, i.e. Rs.9,99,990.
• Business: branding, manufacturing, marketing and distribution of affordable premium pet grooming, wellness and hygiene products. Country of presence: India.

Related party angle

• It is a related party with one common director, Mr. Ravikanth Naga Pattabhi Chopperla, who holds 80,000 equity shares, constituting 80% of the target's equity share capital.
• The update states no promoter or promoter group entity has direct interest, and the transaction is proposed on an arm's length basis.

Deal mechanics

• Consideration: cash.
• Indicative completion: on or before June 30, 2027.
• The exact issue price/valuation will be determined as per applicable regulatory valuation rules at the time of execution, so the final percentage of holding or control is yet to be fixed; disclosure will follow on completion.
• No governmental or regulatory approvals are stated as applicable.

Strategic reasoning given

The company recently expanded its Main Objects clause, approved by members at the last Annual General Meeting, to include pet care and hygiene activities. The investment is described as aligned with those expanded objects and intended to support commercial synergies, business volume growth through proposed supply/sale arrangements, and long-term strategic value creation.

What happens next

The 1st Extra-Ordinary General Meeting for FY 2026-27 is scheduled for Monday, 26.10.2026 at 11.00 a.m. through video conference or other audio-visual means, where shareholders will vote on these enabling resolutions.

How investors may read it

This is an enabling step, not a completed transaction. Points investors often watch in such cases are the size of the sale limit relative to the company's own scale, the fact that the counterparty is newly incorporated with a small capital base, and that a director holds 80% of it — all of which make the arm's length pricing and eventual valuation the key details to track.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.